1. Jo S H, et al. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial[J]. Journal of the American College of Cardiology, 2006, 48(5): 924-930.